Joseph R. Osborne, M.D, Ph.D.

CEO/co-Founder, Rad Health Equity
Chief, Molecular Imaging and Therapeutics, Weill Cornell Medicine

Joseph Osborne M.D., Ph.D. is the Chief of Molecular Imaging and Therapeutics, Professor of Radiology at Weill Cornell Medicine and Attending Radiologist at NewYork-Presbyterian/Weill Cornell Medicine. 

Dr. Osborne earned his M.D. at Columbia College of Physicians and Surgeons and his Ph.D. in Biochemistry at Columbia’s Graduate School of Arts and Sciences in New York, NY. After an internship in the department of Internal Medicine at the Washington Hospital Center in Washington, D.C., Dr. Osborne completed his residency training in Diagnostic Radiology at Columbia Presbyterian Hospital followed by a fellowship training in Nuclear Medicine. Dr. Osborne also completed post-doctoral training at Memorial Sloan Kettering Cancer Center in New York, NY.

Dr.  Osborne is the Director of the Rad Health Equity lab where his goal is to promote equitable and cost-effective diagnostics, theranostics and precision medicine.  In line with this goal, he is formerly the principle investigator on an NIH Academic Industrial Partnership RO1 grant “A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use” and the Dean’s Health Disparity Research Award “Prostate Cancer Health Impact Program (pCHIP).”

Currently, Dr. Osborne is the Assistant Director for Clinical Trial Participation at the Meyer Cancer Center where he will be addressing programmatic strengthening of the clinical trials infrastructure through the Office of Community Outreach and Engagement.